Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

NCT00038870 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Acute Myelogenous Leukemia
Chronic Myelogenous Leukemia

Interventions

BIOLOGICAL: Dendritic Cell Activated Lymphocyte

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]